Skip to main content
. 2018 Jan 16;2018(1):CD006847. doi: 10.1002/14651858.CD006847.pub2

Chen 2007.

Methods Design: parallel‐group
 Randomisation: yes, method not stated
 Blinding: nil
 Withdrawals: stated
Participants Setting: single‐centre study, hospital outpatient department
Number eligible: 48
 Number enrolled: 48
 Number in treatment group: 21
 Number in control group: 27
 Number of withdrawals (treatment/control): 6/0
 Number completing trial (treatment/control): 15/27
 Age range: treatment 39 to 80; control 35 to 85
 Sex: 25 M, 23 F
 Ethnicity: Ethnic Chinese
 NSCLC diagnosis: histologic or cytologic diagnosis of stage IV adenocarcinoma
Inclusion criteria: failed previous chemotherapy with ?2 regimens (including taxanes and platinum‐based chemotherapy); clinically measurable disease; no previous radiotherapy directed at lesions; adequate bone marrow reserve with WBC count < 4000/mm3; platelets < 100,000/mm3; haemoglobin < 10 g/dL; life expectancy of > 2 months
 Exclusion criteria: inadequate liver function (total bilirubin > 1.5 times upper limit of normal and alanine and aspartate aminotransferase levels > 3 times upper limit of normal) or inadequate renal function with creatinine levels > 2 mg/dL
 Baseline characteristics of treatment/control groups: no difference between groups
Interventions 250 mg gefitinib daily
 Vinorelbine (15 mg/m2) on day 1, 250 mg gefitinib daily on days 2 to 14 every 2 weeks
Outcomes Overall survival
 Time to progression, 1‐year progression‐free survival
 Tumour response ‐ RECIST
 ASEs ‐ NCI‐CTC
 EGFR FISH examination
 LCS of FACT‐L
Notes
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk Quote: "Eligible patients were randomized..." but no further information provided
Comment: there was insufficient information to permit a clear judgement of risk of bias
Allocation concealment (selection bias) Unclear risk No information provided
Comment: there was insufficient information to permit a clear judgement of risk of bias
Blinding (performance bias and detection bias) 
 All outcomes Low risk No blinding but review authors judge that outcome is not likely to be influenced by lack of blinding
Comment: this was judged as a low risk of bias
Incomplete outcome data (attrition bias) 
 All outcomes High risk No information provided
Comment: this was judged as a high risk of bias
Selective reporting (reporting bias) Low risk All prespecified outcomes were reported
Comment: this was judged as a low risk of bias
Other bias Unclear risk There were no declarations of potential conflicts of interest or indication of funding or support
Comment: there was insufficient information to permit a clear judgement of the risk of bias